Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
Osteoprotegerin and the develo...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
Osteoprotegerin and the development of myeloma bone disease
Bibliográfalaš dieđut
Váldodahkkit:
Croucher, P
,
Shipman, C
,
Vanderkerken, K
Materiálatiipa:
Conference item
Almmustuhtton:
2004
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Geahča maid
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Dahkki: Croucher, P, et al.
Almmustuhtton: (2003)
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Dahkki: Croucher, P, et al.
Almmustuhtton: (2001)
Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
Dahkki: De Leenheer, E, et al.
Almmustuhtton: (2004)
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Dahkki: Croucher, P, et al.
Almmustuhtton: (2001)
Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
Dahkki: Croucher, P, et al.
Almmustuhtton: (2000)